Oruka Therapeutics (ORKA) earnings, Nov 9, 2026: EPS −15%, stock +1.7%
In brief
Oruka Therapeutics reported on Nov 9, 2026. Earnings per share changed −15% year over year, 5.1% below the estimate; revenue 0%. The stock opened with a +1.7% gap and closed the day +1.7% (Nov 9, 2026). The stock is now 9.5% below its 52-week high, +276.8% over 12 months. Next report: Mar 11, 2027.
EPS vs estimate−5.1%
EPS, YoY−15%
Revenue, YoY0%
Gap · day+1.7% · +1.7%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 13, 2026 | +0.3% | +1.1% |
| Aug 10, 2026 | +2.3% | −0.4% |
| Nov 9, 2026 | +1.7% | +1.7% |
Next-quarter estimates, ratings and the ORKA chart are in the terminal.
Open the terminalFAQ
When is Oruka Therapeutics's next earnings report?
Mar 11, 2027. The date comes from daily data and is corrected if the company moves it.
How did Oruka Therapeutics stock react to the report?
Opening gap +1.7%, day's result +1.7%.
Did Oruka Therapeutics's earnings grow?
Earnings per share fell 15% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.